First gram-scale monthly oral capsule
“Just one monthly SUTOL capsule. No daily pills, no painful injections.”
SUTOL Bio
SUTOL Bio, Inc. (SUTOL Bio) is a next-generation biotech company developing the Monthly Oral Capsule Platform, a first-in-class oral delivery system engineered to reside safely in the stomach and provide continuous drug release for over 30 days following a single administration.
Originating from the MIT Langer/Traverso Labs, SUTOL integrates advanced materials science, biomedical engineering, and translational research to enable once-monthly oral therapies that replace long-acting injectables and transform adherence in chronic disease management.